Cargando…
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
The development of effective vaccines to combat infectious diseases is a complex multi-year and multi-stakeholder process. To accelerate the development of vaccines for coronavirus disease 2019 (COVID-19), a novel pathogen emerging in late 2019 and spreading globally by early 2020, the United States...
Autores principales: | Bok, Karin, Sitar, Sandra, Graham, Barney S., Mascola, John R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328682/ https://www.ncbi.nlm.nih.gov/pubmed/34348117 http://dx.doi.org/10.1016/j.immuni.2021.07.017 |
Ejemplares similares
-
COVID-19 vaccine development: milestones, lessons and prospects
por: Li, Maochen, et al.
Publicado: (2022) -
Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine
por: Thiel, Natalie, et al.
Publicado: (2021) -
Accelerating antiviral drug discovery: lessons from COVID-19
por: von Delft, Annette, et al.
Publicado: (2023) -
Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks
por: Wagner, Ralf, et al.
Publicado: (2021) -
Developmental Milestones in Children’s Environmental Health
por: Etzel, Ruth A.
Publicado: (2010)